Related Experiment Videos

ARF differentially modulates apoptosis induced by E2F1 and Myc

Jamie L Russell1, John T Powers, Robert J Rounbehler

  • 1Department of Carcinogenesis, Science Park-Research Division, University of Texas M. D. Anderson Cancer Center, Smithville, Texas 78957, USA.

Insights

The tumor suppressor ARF is not required for E2F1-induced apoptosis and actually inhibits E2F1's apoptotic function. Inactivating ARF enhances E2F1's ability to promote apoptosis and cell cycle progression.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The ARF tumor suppressor is involved in p53-dependent apoptosis.
  • E2F1 transcription factor promotes proliferation and apoptosis.
  • E2F1 regulates the ARF gene, suggesting ARF's role in E2F1-induced apoptosis.

Purpose of the Study:

  • To investigate the role of ARF in E2F1-induced apoptosis.
  • To determine if ARF is necessary for E2F1 to induce apoptosis.
  • To elucidate the relationship between ARF and E2F1 in vivo and in vitro.

Main Methods:

  • Experiments were conducted in transgenic epidermis in vivo.
  • Studies utilized mouse embryo fibroblast cultures in vitro.
  • Assessed apoptosis induction by E2F1 and Myc in the presence and absence of ARF.

Main Results:

  • ARF is unnecessary for E2F1-induced apoptosis.
  • Inactivation of ARF enhances E2F1's apoptotic function.
  • ARF inactivation cooperates with E2F1 to promote S-phase entry.
  • E2F1 induces p53 accumulation and phosphorylation in the absence of ARF.
  • Myc-induced apoptosis is diminished without ARF.

Conclusions:

  • ARF acts as a negative regulator of E2F1 activity.
  • ARF is not required for E2F1-mediated apoptosis.
  • The absence of ARF potentiates E2F1's pro-apoptotic and proliferative effects.

Related Concept Videos